The use of Bayesian hierarchical models for adaptive randomization in biomarker-driven phase II studies. [electronic resource]
- Journal of biopharmaceutical statistics 2015
- 66-88 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1520-5711
10.1080/10543406.2014.919933 doi
Bayes Theorem Biomarkers, Tumor--metabolism Clinical Trials, Phase II as Topic--statistics & numerical data Computer Simulation Humans Models, Statistical Neoplasms--drug therapy Predictive Value of Tests Random Allocation Randomized Controlled Trials as Topic--statistics & numerical data Sample Size Treatment Outcome